CA45422-2A - 0x00000000000067A3

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
October 1, 2025 - 1:30pm
End Date: 
January 15, 2026 - 7:00am

Study Details

Study Number: CA45422
Group Number: 2A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $8,750.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 23

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 5 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date
Wednesday 9/24/2025
Tuesday 9/30/2025

Doctor Exam Dates:

Event Day Event Date
Wednesday 9/24/2025
Tuesday 9/30/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 10/1/2025 1:30:00 PM Sunday 10/5/2025 8:00:00 AM 1 Lincoln
Phone participant Thursday 10/9/2025 11:00:00 AM 1 Lincoln
Return Thursday 10/16/2025 7:00:00 AM Thursday 10/16/2025 8:00:00 AM 1 Lincoln
Return Thursday 10/30/2025 7:00:00 AM Thursday 10/30/2025 8:00:00 AM 1 Lincoln
Return Wednesday 11/26/2025 6:00:00 AM Wednesday 11/26/2025 7:00:00 AM 1 Lincoln
Return Thursday 12/18/2025 6:00:00 AM Thursday 12/18/2025 7:00:00 AM 1 Lincoln
Return Thursday 1/15/2026 6:00:00 AM Thursday 1/15/2026 7:00:00 AM 1 Lincoln